Semler Scientific Acquires 185 Bitcoin While Total Holdings Reach 4,449 Bitcoin

Semler Scientific acquired 185 Bitcoin between May 23rd and June 3rd for approximately $20 million, at an average price of $107,974 per coin.

The purchase was funded through proceeds from the company’s at-the-market (ATM) equity offering program.

“We continue to accretively grow our Bitcoin arsenal using operating cash flow and proceeds from debt and equity financings,” said Chairman Eric Semler.

“And we are excited to launch the Semler Scientific dashboard today on our website to provide the public with regularly updated information on our Bitcoin holdings and other key metrics.”

Since launching the ATM program in April 2025, the company has raised approximately $136.2 million through the sale of over 3.6 million common shares.

As of June 3rd, Semler holds 4,449 Bitcoin, acquired at a total cost of $410 million, with an average purchase price of $92,158. The holdings are currently valued at about $446.2 million.

On X, Semler wrote: “SMLR acquires 185 Bitcoins for $20 million and has generated BTC Yield of 26.7% YTD. Now holding 4,449 $BTC.”

$SMLR acquires 185 #Bitcoins for $20 million and has generated BTC Yield of 26.7% YTD. Now holding 4,449 $BTC. 🚀
— Eric Semler (@SemlerEric) June 4, 2025

Semler uses BTC Yield as a key performance indicator (KPI) to evaluate its Bitcoin strategy.

According to the company’s Form 8-K, the metric is intended to “supplement an investor’s understanding” of its decision to fund Bitcoin purchases through equity or convertible instruments.

Year-to-date, the BTC Yield stands at 26.7%.

In Q1 2025, Semler reported an operating loss of $31.1 million, compared to a $7.0 million profit in the same period last year.

Revenue declined 44% year-over-year to $8.8 million, while operating expenses rose to $39.9 million, largely due to a $29.8 million contingent liability tied to a potential Department of Justice settlement.

Commenting on the company’s operations, CEO Doug Murphy-Chutorian said, “our healthcare business is seeing green shoots from the cardiovascular product line that we introduced to our large enterprise customer base this year. We are expecting growth and cash generation from these FDA-cleared products and services, which will add to our bitcoin treasury strategy.”